Effect and mechanism of Intratumoral Gemella haemolysans on development of esophageal squamous cell carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400088529

Enrollment

Unknown

Registered

2024-08-20

Start date

2024-09-01

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal squamous cell carcinoma

Interventions

Study Group:No

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with esophageal squamous cell carcinoma; 2. Patients who plan to undergo radical resection of esophageal cancer; 3. Patients who signed the informed consent for experimental study of the remaining surgical specimens.

Exclusion criteria

Exclusion criteria: 1.Patients under 18 years old and over 90 years old; 2. Preoperative diagnosis of patients with malignant tumors of other sites; 3. Patients whose physical condition is not suitable for surgery; 4. Patients not from Sichuan and Chongqing areas.

Design outcomes

Primary

Measure	Time frame
16S ribosomal RNA gene sequencing;	—

Secondary

Measure	Time frame
Untargeted Metabolomics in plasma;	—

Countries

China

Contacts

Public ContactTianyang Zeng

The First Affiliated Hospital of Chongqing Medical University

745579619@qq.com+86 187 2323 0246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026